Почетна › Кронова болест › Тексас › San Antonio
Kliničke studije za Кронова болест u gradu San Antonio, TX
14 studija za Кронова болест traži učesnike na lokacijama u gradu San Antonio i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Тражи се учесникФаза 3
- Southern Star Research Institute ( Site 0299), San Antonio
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Тражи се учесникФаза 3
- Southern Star Research Institute ( Site 5000), San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Тражи се учесникФаза 2
- Southern Star Research Institute, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Тражи се учесникФаза 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Тражи се учесникФаза 2
- Southern Star Research Institute, San Antonio
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2/3
- Southern Star Research Institute, LLC, San Antonio
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Gastroenterology Research of America, LLC, San Antonio
- Southern Star Research Institute, LLC, San Antonio
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2
- Southern Star Research Institute, LLC, San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Тражи се учесникФаза 2
- Southern Star Research Institute /ID# 280822, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Тражи се учесникФаза 2
- Sun Research Institute /ID# 266723, San Antonio
- Southern Star Research Institute /ID# 278124, San Antonio
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Тражи се учесникФаза 3
- Southern Star Research Institute, LLC, San Antonio
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2
- Southern Star Research Institute, LLC, San Antonio
Studije za Кронова болест u drugim gradovima
- New York City, NY33 студија
- St. Louis, MO19 студија
- Miami, FL19 студија
- Orlando, FL19 студија
- Boston, MA18 студија
- Houston, TX17 студија
- Atlanta, GA16 студија
- Tyler, TX16 студија
- San Diego, CA15 студија
- Cleveland, OH15 студија
- Colorado Springs, CO14 студија
- Los Angeles, CA13 студија
Ostale studije u gradu San Antonio
- Немалоклетни карцином плућа60 студија
- Рак дојке45 студија
- Метастатски карцином44 студија
- Колоректални карцином43 студија
- Рак (све врсте)41 студија
- Гојазност39 студија
- Dijabetes tipa 237 студија
- Гојазност34 студија
- Рак јајника33 студија
- Рак панкреаса33 студија
- Рак плућа27 студија
- Рак простате27 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.